Stroke management and outcomes in low-income and lower-middle-income countries: a meta-analysis of 8535 patients.

World Bank income classification low-income countries meta-analysis poststroke outcomes stroke mortality rates vascular disorders

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
01 10 2023
Historique:
received: 12 12 2022
accepted: 09 02 2023
medline: 23 10 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: epublish

Résumé

Strokes affect almost 13 million new people each year, and whereas the outcomes of stroke have improved over the past several decades in high-income countries, the same cannot be seen in low-income and lower-middle-income countries. This is the first study to identify the availability of diagnostic tools along with the rates of stroke mortality and other poststroke complications in low-income and lower-middle-income countries. A review of the literature was completed with a search of the MEDLINE, Embase, and Scopus databases, with adherence to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Studies were included if they reported any outcomes of stroke in low-income and lower-middle-income countries as designated by the World Bank classification. A meta-analysis calculating pooled prevalence rates of diagnostic characteristics and stroke outcomes was completed for all endpoint variables. A total of 19 studies were included, of which 6 came from Ethiopia, 3 from Zambia, and 2 each from Tanzania and Iran. Single studies from Zimbabwe, Botswana, Senegal, Cameroon, Uganda, and Sierra Leone were included. A total of 5265 (61.7%) patients had an ischemic stroke, 2124 (24.9%) had hemorrhagic stroke, with the remaining 1146 (13.4%) having an unknown type. Among 6 studies the pooled percentage of patients presenting to hospital within 1 day was 48.37% (95% CI 38.59%-58.27%; I2 = 97.0%, p < 0.01). The pooled in-hospital mortality rate was 19.81% (95% CI 15.26%-25.31%; I2 = 91%, p < 0.01), but was higher in a hemorrhagic subgroup (27.07% [95% CI 22.52%-32.15%; I2 = 54%, p = 0.05]) when compared to an ischemic group (13.16% [95% CI 8.60%-19.62%; I2 = 87%, p < 0.01]). The 30-day pooled mortality rate was 23.24% (95% CI 14.17%-35.70%; I2 = 93%, p < 0.01). At 30 days, the functional independence (modified Rankin Scale score 0-2) pooled rate was 13.10% (95% CI 7.50%-21.89%; I2 = 82%, p < 0.01). A severe healthcare disparity is present in low-income and lower-middle-income countries, where there is delayed diagnosis of strokes and increased rates of poor clinical outcomes for these patients.

Identifiants

pubmed: 37856884
doi: 10.3171/2023.2.JNS222807
doi:

Types de publication

Review Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1042-1051

Auteurs

Alexander O Aguirre (AO)

1Jacob School of Medicine and Biomedical Sciences, University at Buffalo, New York.

James L Rogers (JL)

2Vanderbilt University School of Medicine, Nashville, Tennessee.

Taylor Reardon (T)

3Kentucky College of Osteopathic Medicine, University of Pikeville, Kentucky.

Nathan A Shlobin (NA)

4Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Alexander M Ballatori (AM)

5Keck School of Medicine of the University of Southern California, Los Angeles, California.

Nolan J Brown (NJ)

6Department of Neurological Surgery, University of California, Irvine, California; and.

Julian Gendreau (J)

7Department of Biomedical Engineering, Johns Hopkins Whiting School of Engineering, Baltimore, Maryland.

Shane Shahrestani (S)

5Keck School of Medicine of the University of Southern California, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH